About Coloplast
Coloplast is a company based in Humlebaek (Denmark) founded in 1957. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 16,640 employees as of September 30, 2024. Coloplast has completed 7 acquisitions, including Atos Medical, Comfort Medical and IncoCare. Coloplast offers products and services including Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products. Coloplast operates in a competitive market with competitors including Molnlycke Health Care, ConvaTec, ConvaTec Group, VulCur Medtech and Rubitection, among others.
- Headquarter Humlebaek, Denmark
- Employees 16640 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Coloplast A/S Class B
-
Annual Revenue
$3.77 B (USD)10.33as on Sep 30, 2024
-
Net Profit
$703.48 M (USD)5.62as on Sep 30, 2024
-
EBITDA
$1.21 B (USD)10.72as on Sep 30, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
16640
as on Sep 30, 2024
-
Investments & Acquisitions
Atos Medical
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Coloplast
Coloplast is a publicly listed company on the OMXCOP with ticker symbol COLO_B in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Coloplast
Coloplast offers a comprehensive portfolio of products and services, including Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products.
Ostomy bags and supports are provided for patients.
Intermittent catheters and devices are offered for continence.
Implants and surgical tools are supplied for urology.
Transanal irrigation systems are developed for bowel management.
Wound dressings and biologics are provided for healing.
People of Coloplast
Unlock access to complete
Unlock access to complete
Software Development Team
77 people
Sales and Marketing
47 people
Human Resources and Administration
45 people
Leadership Team
40 people
Finance and Accounting
29 people
Product Management Team
21 people
Senior Team
21 people
Board Team
7 people
Unlock access to complete
Funding Insights of Coloplast
Investments & Acquisitions by Coloplast
Coloplast has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Atos Medical, Comfort Medical and IncoCare.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Devices for personal and private medical conditions are manufactured.
|
2014 | ||||
|
Home delivery of catheter and ostomy supplies is provided.
|
2010 | ||||
|
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
2007 |
Financial Statements - Coloplast
Coloplast Comparisons
Competitors of Coloplast
Coloplast operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Molnlycke Health Care, ConvaTec, ConvaTec Group, VulCur Medtech and Rubitection, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of wound care and surgical procedure solutions
|
|
| domain | founded_year | HQ Location |
Portfolio of wound care, ostomy care, stomacare, fecal management
|
|
| domain | founded_year | HQ Location |
Devices for chronic disease management are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Developer of a device for the treatment of chronic wounds
|
|
| domain | founded_year | HQ Location |
An assessment system for early bedsore detection is provided.
|
Frequently Asked Questions about Coloplast
Coloplast was founded in 1957.
Coloplast is headquartered in Humlebaek, Denmark.
Kristian Villumsen is the current CEO of Coloplast.
As of Sep 30, 2024, the latest employee count at Coloplast is 16,640.
Annual revenue of Coloplast is $3.77B as on Sep 30, 2024.
Intimate healthcare solutions are developed by Coloplast to support people with specific medical needs. Focus is placed on areas such as ostomy care, continence care, interventional urology, bowel care, advanced wound care, and voice and respiratory care. Products and services are tailored to improve quality of life for users across over 100 countries. Support is also extended to healthcare professionals through education and tools to enhance patient care. Innovation and empathy are prioritized to address the unique challenges faced by individuals with intimate healthcare conditions.
Coloplast's top competitors include ConvaTec Group, Molnlycke Health Care and ConvaTec.
Coloplast offers Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products.
Yes, Coloplast is publicly traded on OMXCOP under the ticker symbol COLO_B.
Coloplast has made 7 acquisitions, including Atos Medical, Comfort Medical, and IncoCare.
The ticker symbol of Coloplast is COLO_B on OMXCOP.